Drug intelligence / Profile preview

SanJoint UC

Development stage
Unknown
Lead developer
Sanrey Therapeutics
Modality
Recombinant Proteins and Enzymes
Administration
Oral
01

Overview

SanJoint UC is a branded pharmaceutical and nutraceutical product developed by Sanrey Therapeutics, an Indian pharmaceutical company based in Chennai. It is specifically formulated for orthopedic and rheumatological applications, primarily the management of osteoarthritis, rheumatoid arthritis, and chronic joint pain. The active ingredient, Undenatured Type II Collagen (UC-II), is a protein derived from chicken sternum cartilage that retains its native triple-helix structure. Unlike hydrolyzed collagen, which is broken down into peptides, UC-II functions via a mechanism known as oral tolerance. Upon ingestion, it interacts with gut-associated lymphoid tissue (GALT), specifically Peyer's patches in the small intestine. This interaction triggers the production of regulatory T cells (Tregs) specific to Type II collagen. These cells then migrate to the joints, where they release anti-inflammatory cytokines such as IL-10 and TGF-beta, helping to suppress the immune-mediated destruction of joint cartilage and promoting joint mobility and comfort.

Brand names
SanJoint UC
Other names
Undenatured Type II CollagenUC-II
02

Targets

COL2 (Type II Collagen)

Beyond the preview

Go deeper on SanJoint UC.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SanJoint UC.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call